Samenvatting
Doel. Het beschrijven van de klinische en moleculair-genetische karakteristieken van patiëntn met het Bloom-syndroom (BS ) in Nederland in vergelijking met het internationale cohort BS-patiënten van de Bloom’s Syndrome Registry (BSR).
Patiënten. Voor deze studie werd contact gezocht met alle klinisch genetische centra in Nederland, waardoor 15 patiënten met BS werden geëdentificeerd. Van deze patiënten werden klinische en moleculair-genetische gegevens verzameld en vergeleken met de publiekelijk beschikbare data van de 256 patiënten uit de BSR.
Conclusie. We concluderen dat de prevalentie van maligniteiten en niet-insulineafhankelijke diabetes mellitus bij BS-patiënten in Nederland wat lijkt te verschillen ten opzichte van het BSR-co-hort. We beschrijven een maligniteit (rabdomyosarcoom) die niet eerder beschreven werd bij patiëntn met BS en rapporteren twee niet eerder beschreven mutaties.
Summary
Aim. To describe the clinical and molecular genetic characteristics of Bloom syndrome (BS) patients in the Netherlands, in comparison with the international Bloom syndrome cohort as described in the Bloom’s Syndrome Registry (BSR).
Patients. For this study, all clinical genetic departments in the Netherlands were contacted, which identified 15 patients with Bloom syndrome. Of these patients, clinical and molecular genetic data were gathered and compared with the public available data of the BSR.
Conclusions. We conclude that the prevalence of malignancies and non-insulin dependent diabetes mellitus in BS patients in the Netherlands seems to differ from patients from the BSR.We describe a malignancy (rhabdomyosarcoma) which has not previously been reported in relation to BS and report on two mutations that have not yet been described.
Literatuur
Shahrabani-Gargir L, Shomrat R, Yaron Y, et al. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin. Genet Test. 1998;2:293–6.
Li L, Eng C, Desnick RJ, German J, Ellis NA. Carrier frequency of the Bloom syndrome blmAsh mutation in the Ashkenazi Jewish population. Mol Genet Metab. 1998;64:286–90.
Roa BB, Savino CV, Richards CS. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation. Genet Test. 1999; 3:219–21.
Ellis NA, Ciocci S, Proytcheva M, et al. The Ashkenazic Jewish Bloom syndrome mutation blmAsh is present in non-Jewish Americans of Spanish ancestry. Am J Hum Genet. 1998;63:1685–93.
German J, Bloom D, Passarge E. Bloom’s syndrome XI. Progress report for 1983. Clin Genet. 1984;25:166–74.
Passarge E. Bloom’s syndrome: the German experience. Ann Genet. 1991;34:179–97.
Legum C, Furman N, Diamant S. Bloom’s syndrome in an Iranian Jewish male. Ann Genet. 1991;34:198–200.
Sanz MM, German J. Bloom’s Syndrome. www.ncbi.nlm.nih.gov/books/NBK1398. Geraadpleegd 17 april 2013.
German J. Bloom’s syndrome. I. Genetical and clinical observations in the first twenty-seven patients. Am J Hum Genet. 1969;21:196–227.
German J. Bloom syndrome: a mendelian prototype of somatic mutational disease. Medicine (Baltimore). 1993;72:393–406.
German J, Archibald R, Bloom D. Chromosomal breakage in a rare and probably genetically determines syndrome of man. Science. 1965;148: 506–7.
Hennekam RCM, Krantz ID, Allanson JE. Gorlin’s syndromes of the head and neck, 5th ed. New York: Oxford University Press, 2010.
Gennery A. Bloom syndrome. www.uptodate.com. Geraadpleegd 27 augustus 2012.
Chisholm CA, Bray MJ, Karns LB. Successful pregnancy in a woman with Bloom syndrome. Am J Med Genet. 2001;102:136–8.
Mulcahy MT, French M. Pregnancy in Bloom’s syndrome. Clin Genet. 1981;19:156–8.
Diaz A, Vogiatzi MG, Sanz MM, German J. Evaluation of short stature, carbohydrate metabolism and other endocrinopathies in Bloom’s syndrome. Horm Res. 2006;66:111–7.
German J. Bloom’s syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet. 1997;93:100–6.
Bloom’s Syndrome Registry. http://med.cornell.edu/bsr. Geraadpleegd 27 augustus 2012.
Bryant EM, Hoehn H, Martin GM. Normalisation of sister chromatid exchange frequencies in Bloom’s syndrome by euploid cell hybridisation. Nature. 1979;279:795–6.
German J, Crippa LP, Bloom D. Bloom’s syndrome. III. Analysis of the chromosome aberration characteristic of this disorder. Chromosoma. 1974;48:361–6.
Bartram CR, Koske-Westphal T, Passarge E. Chromatid exchanges in ataxia telangiectasia, Bloom syndrome, Werner syndrome, and xeroderma pigmentosum. Ann Hum Genet. 1976;40:79–86.
Cohen MM, Levy HP. Chromosome instability syndromes. Adv Hum Genet. 1989;18:43–71.
Bennett RJ, Keck JL. Structure and function of RecQ DNA helicases. Crit Rev Biochem Mol Biol. 2004;39:79–97.
Amor-Gueret M. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. Cancer Lett. 2006;236:1–12.
Monnat RJ Jr. Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology. Semin Cancer Biol. 2010;20:329–39.
German J, Sanz MM, Ciocci S, et al. Syndromecausing mutations of the BLM gene in persons in the Bloom’s Syndrome Registry. Hum Mutat. 2007;28:743–53.
Amor-Gueret M, Dubois-d’Enghien C, Lauge A, et al. Three new BLM gene mutations associated with Bloom syndrome. Genet Test. 2008;12:257–61.
Sanz MM, German J. Bloom’s syndrome. www.ncbi.nlm.nih.gov/books/NBK1398. Geraadpleegd 17 augustus 2012.
Author information
Authors and Affiliations
Corresponding author
Additional information
Auteurs
Mw. drs. Saskia M.J. Hopman en dhr. dr. Johannes (Hans) H.M. Merks, afdeling Kinderoncologie, Emma Kinderziekenhuis AMC, Amsterdam. Mw. dr. Emilia K. Bijlsma, afdeling Klinische Genetica, LUMC, Leiden. Dhr. dr. Henk Boot, afdeling Maagdarm-leverziekten, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam. Mw. dr. A. (Lia) C. Knegt, afdeling Klinische Genetica, AMC, Amsterdam. Mw. dr. Veerle Langenhorst, afdeling Kindergeneeskunde, Isala klinieken, Zwolle. Dhr. Michiel H.D. Schoenaker, afdeling Kindergeneeskunde, Radboudumc, Nijmegen. Mw. drs. Kyra E. Stuurman, afdeling Klinische Genetica, VUmc, Amsterdam. Mw. drs. Joke B.G.M. Verheij, afdeling Genetica, Rijksuniversiteit Groningen, UMCG, Groningen. Mw. dr. Anja Wagner, afdeling Klinische Genetica, Erasmus MC, Rotterdam. Mw. dr. Corry M. Weemaes, afdeling Kindergeneeskunde, Radboudumc, Nijmegen. Mw. dr. Petra Zwijnenburg, afdeling Klinische Genetica, VUmc, Amsterdam. Mw. dr. Erna Michiels, afdeling Kinderoncologie, Erasmus MC-Sophia Kinderziekenhuis, Rotterdam. Mw. drs. Irma Kluijt, afdeling Klinische Genetica, AMC, Amsterdam.
Rights and permissions
About this article
Cite this article
Hopman, S., Merks, J., Bijlsma, E. et al. Het Bloom-syndroom in Nederland. TIJDSCHR. KINDERGENEESKUNDE 81, 148–158 (2013). https://doi.org/10.1007/s12456-013-0178-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12456-013-0178-8